Fig. 1From: Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic markerPrincipal component analysis of the 836 proteins that were quantified in atleast 50% of distal cholangiocarcinoma samples (pink) and controls (green)Back to article page